3-[2-(dimethylamino)ethyl]-4-[3-(3-pyrazol-1-ylphenyl)imidazo[1,2-a]pyridin-7-yl]benzamide
C27H26N6O — CID 142784535
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-(dimethylamino)ethyl]-4-[3-(3-pyrazol-1-ylphenyl)imidazo[1,2-a]pyridin-7-yl]benzamide
3-[2-(dimethylamino)ethyl]-4-[3-(3-pyrazol-1-ylphenyl)imidazo[1,2-a]pyridin-7-yl]benzamide (PubChem CID 142784535) has the molecular formula C27H26N6O and a molecular weight of 450.55 g/mol. Its IUPAC name is 3-[2-(dimethylamino)ethyl]-4-[3-(3-pyrazol-1-ylphenyl)imidazo[1,2-a]pyridin-7-yl]benzamide.
Molecular Properties
| Compound Name | 3-[2-(dimethylamino)ethyl]-4-[3-(3-pyrazol-1-ylphenyl)imidazo[1,2-a]pyridin-7-yl]benzamide |
|---|---|
| PubChem CID | 142784535 |
| Molecular Formula | C27H26N6O |
| Molecular Weight | 450.55 g/mol |
| Exact Mass | 450.22 |
| IUPAC Name | 3-[2-(dimethylamino)ethyl]-4-[3-(3-pyrazol-1-ylphenyl)imidazo[1,2-a]pyridin-7-yl]benzamide |
| SMILES | CN(C)CCc1cc(C(N)=O)ccc1-c1ccn2c(-c3cccc(-n4cccn4)c3)cnc2c1 |
| InChI | InChI=1S/C27H26N6O/c1-31(2)13-9-19-15-22(27(28)34)7-8-24(19)20-10-14-32-25(18-29-26(32)17-20)21-5-3-6-23(16-21)33-12-4-11-30-33/h3-8,10-12,14-18H,9,13H2,1-2H3,(H2,28,34) |
| InChIKey | YWDKAALOJMTJMX-UHFFFAOYSA-N |
| XLogP | 4.06 |
| TPSA | 81.45 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 450.55 |
| LogP ≤ 5 | 4.06 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142784535 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.